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Neonatal bacterial meningitis is devastating, with attendant high mortality and neurological
sequelae. We, therefore, aimed to delineate its current incidence, etiologic, clinical, laboratory spectra, and the
effect of steroid therapy on the outcome.
Babies admitted from1992 to 1995 in the Special Care Baby Unit of the University of
Maiduguri Teaching Hospital, Maduguri, Nigeria, with bacterial meningitis were studied prospectively.
Neonatal bacterial meningitis was confirmed if the cerebrospinal fluid (CSF) microbiological, chemical,
immunological and clinical criteria were satisfied. Detailed neurological follow-up was made.
Sixty-nine cases of neonatal bacterial meningitis were encountered, (25 were early-onset, and 44 late-
onset); the incidence was 6.5/1000 live births. 22 Positive CSF cultures were grown in early-onset meningitis,
and 28 in late-onset disease. Low birth weight showed higher risk of bacterial meningitis and it was
significantly more likely in the preterm. X =24.19, = 0.000001). Gram-negative pathogens were more
isolated (28/50, 56%); (11) being the commonest, while of the Gram-positive pathogens
was most predominant overall (13/50). Concomitant blood culture was positive in
39/50 (78%), inclusive of all 22 “definite” early-onset disease. The CSF WBC was minimally raised (25-30 x
10 /L) in 11 (22%) of “definite” neonatal bacterial meningitis. Detection of unusual pathogens was
noteworthy: (2) and (2), contributing 0.6 and 2.2 per 1000 live births and
admissions, respectively. Overall mortality was 24.6%. Of the forty survivors, 9(22.5%) had neurological
sequelae: sensorineural hearing deficit (3), hydrocephalus (2), subdural effusion (2), hemiparesis (1), afebrile
(recurrent) seizure (1), and there was reduced developmental quotients at 24 months follow-up in 33.
Dexamethasone therapy decreased mortality significantly; = 0.0004.
The new information highlighted by this research includes the lack of Group B Streptococcus
isolation, the finding as significant pathogens,
usefulness of blood cultures in the detection of neonatal bacterial meningitis, increasing resistance of Gram-
positive neonatal pathogens to cloxacillin, low CSF WBC, and the finding that the adjunctive use of




NEONATAL BACTERIAL MENINGITIS AND DEXAMETHASONE
ADJUNCTIVE USAGE IN NIGERIA
INTRODUCTION
.
Neonatal bacterial meningitis is a troublesome and
life-threatening infection that a newborn and the
family can encounter. Despite advancements in its
treatment over the past 50-60 years, mortality
remains high at between 25 to 50 percent.
Neurological sequelae are common among survivors
with involvement of more than 25% and up to 41%
documented. Furthermore, 6-12% hearing
impairment has been suggested
Evaluations based on a geographically defined
population in the USA have shown rates of 0.2 - 0.5





Correspondence: Prof K IAirede
E mail: airedek@yahoo.com
Reviews from Europe and Australia show similar
rates but with particularly high rates of 0.7 - 1.9 per
1000 reported for theAfrican continent.
There is evidence that the incidence is on the increase
with a changing trend in the causative organisms in
some communities. Group B streptococci (GBS)
and are common in the
developed world/affluent societies.
With the continuing scourge of neonatal infections,
particularly bacterial meningitis, we felt it necessary
to prospectively study our neonates over a 4-year
period in the Special Care Baby Unit SCBU), of the
University of Maiduguri Teaching Hospital
(UMTH), Maiduguri, Nigeria. The study set out to
determine the current incidence of neonatal bacterial







spectra, and ascertain the neurodevelopmental
outcome. As a corollary, and in view of the
suggestions on the effects of steroids on bacterial
meningitis, the usefulness or contribution to
outcome of dexamethasone was also assessed.
All babies with definite or probable meningitis were
recruited and studied prospectively over the said
period (1992 to 1995) in SCBU of the UMTH,
Nigeria. The newborn infants had their gestational
ages assessed by using the Dubowitz scoring
system. The UMTH, a centre of excellence for
immunology and infectious diseases, is a regional
and/or referral hospital which lies within theAfrican
“Meningitis belt,” and also serves 3 neighboring
countries, Cameroon, Chad and Niger.
Definite neonatal bacterial meningitis was
diagnosed if a pure growth of a pathogen was
obtained from the primary culture of CSF from a
neonate with the clinical picture of meningitis such
as seizures, poor feeding, temperature instability
and/or stupor. On the other hand, probable neonatal
bacterial meningitis was diagnosed if no organism
was obtained from primary CSF culture, but the
Gram stain was positive or specific bacterial antigen
was detected in CSF, and there was a positive blood







i) Organism isolated from the *CSF,
ii) Positive Gram stain/bacteria seen in CSF,
iii) Blood culture positive with no CSF isolate
but with signs of CSF anomaly
defined as greater than 100 white cells (mainly
polymorphs) x 10 /Land
CSF protein 1.5g/1 and CSF glucose 1.4
mmol/L or 50% of a simultaneous serum
glucose,
iv) CSF negative but with CSF pleocytosis
and/or disturbance defined as
200 white cells x 10 /L with at least one of the
following:
a) CSF protein 0.75 g/L;
b) CSF glucose 1.4 mmol/L or 40% of a
simultaneous serum glucose;
c) Specific bacterial antigen detected in CSF;
and/or
d) Positive blood culture
v) CSF immunodiagnosis; ELISA, Latex
agglutination
















The neonates with suspected sepsis or meningitis
were usually investigated for meningitis as
previously described, Cases were diagnosed as
neonatal bacterial meningitis if they satisfied any of




If the CSF obtained was traumatic (blood-stained),a
CSF: Blood White cell count (WBC) greater than
normal CSF: Blood WBC ratio by 100 cells/mm was
also accepted as diagnostic of bacterial meningitis.
The CSF was taken from the lumbar region following
usual standard aseptic technique for performance of
lumbar puncture (LP) .
bearers and other cultures deemed as contaminants
were excluded: these included cultures contaminated
with spores taken as aerial contaminants and the
growth of skin commensals. When in doubt, a new
sub-culture of sample was further undertaken. Strict
asepsis was observed in culturing these organisms.
Sensitivity of the isolates to antibiotics was
determined by the Disc diffusion method, using
multidisc sensitivity tests. CSF immunodiagnosis
(qualitative detection of specific bacterial
polysaccharide surface antigens) was done in some
cases using latex agglutination test kit. Viral
cultures were not carried out.
All infants with neonatal bacterial meningitis were
initially treated empirically according to the Unit's
standard policy of gentamicin and cloxacillin
intravenously (i.v.) or intramuscularly (i.m.), and
later from January 1994, of gentamicin and
ceftazidime. The antimicrobial therapy was
adjusted according to the laboratory result.
Antimicrobial therapy was continued for 14 and
twenty-one days for definite Gram-positive and
Gram-negative bacterial meningitis, respectively,
while treatment for probable cases was given for 10 to
14 days. During the first-half (Phase-1) of the study
period, dexamethasone (0.4mg/kg.i.v. bolus,
followed with 0.2mg/kg i.v. every 8 hours for 72
hours) was given only as clinically indicated, i.e.
when there was a suspicion, or definite evidence of
cerebral edema/raised intracranial pressure (ICP). In
the second-half (Phase-2) of study period, however,
the same dose regimen was routinely used in all
alternate cases within one hour of diagnosis, and






Analysis of CSF in our laboratory was carried out by
Gram staining of the centrifuged deposit, WBC
count, protein and glucose estimation, as well as
standard bacteriological methods of culture,
inoculations and identification. All CSF samples
were plated onto chocolate agar plate (CAP), and
primary bacterial cultures were done by inoculations
of deposits on the CAP. These CAPs were of standard
characteristics, and adequate CO atmosphere were
exposed to all specimens. The species of bacteria
were initially identified by their growth and
morphology after primary culture or after extended
incubation, or following enrichment in cooked meat
medium. Strains were speciated and bio-typed
according to the method of Kilian and other standard
laboratory methods. Plates were incubated
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irrespective of presence or not of raised ICP; over the
same 72 hours duration. Additionally, all cases of
raised ICP were concomitantly treated with 20%
mannitol therapy at a dose of 1g/kg every 8 hours for
36 hours, at the end of which dexamethasone was
still continued.
Although, we concede that this methodologic
approach was not the best, it was still worthwhile
comparing both phases since other management
lines remained unchanged.
Since the Institution had no functional Ethical
Committee at the period of study, the Department of
Paediatrics gave accent for the study. Informed
consent was obtained from all parents. Intrathecal or
intraventricular antibiotics was not administered in
any newborn infant.
Full neurological and developmental assessments
were done regularly in the SCBU, at discharge and at
monthly intervals in the follow-up Neonatology
Clinic, by one of the authors. The Griffiths Mental
Development Scales was used to assess
development and the outcome and developmental
status of survivor was ascertained, compared and
categorized at 24 months of age. More detailed
audiological assessment, e.g. brainstem auditory
revoked potentials/responses (BAER) was not
offered due to lack of facility during period of study.
Hearing was, however, assessed by determination of
behavioral and orienting responses. A definite
hearing disability required four consecutive
confirmatory assessments after discharge from the
SCBU. Specific adverse risk criteria for the
confounding variable of possible congenital hearing
loss were clinically reappraised regularly and
caused exclusion from analysis.
The Chi-squared test (X ) and Fisher' exact test using
EPI-6 software package were employed where
applicable, for differences in which ones as regards
incidence, onset and outcome of neonatal bacterial
meningitis the use of steroids, with 95%
confidence intervals. A value less than 0.05 was
taken as significant difference between compared
data.
Over the 4-year study period, 4,745 babies
were born at UMTH, Maiduguri, Nigeria, out of
which 31 babies developed bacterial meningitis.
Thus, the incidence of neonatal bacterial meningitis
for in-born babies was 6.5 per 100 live births.
However, the total SCBU admissions was 1,815, and
when the total neonatal bacterial meningitis was
reflected, a high proportion of 38.0/1000 was
encountered. Thirty-eight babies (out-born with
meningitis) were referred from the neighboring









Also encountered but excluded from analysis were 3
cases that had fungal ( ) meningitis.
There were 25 and 44 cases of early-onset and
late-onset meningitis, respectively. Any proven case
who is = 72 hours of age and that older than 72 hours,
and up to 28 days was referred to as having the early-
onset and late-onset forms of neonatal bacterial
meningitis, respectively. Table IA further highlights
that in general, late-onset disease was relatively more
common in the term, 20/28(71.4%) as against the
preterm infant; 58.5%. However, this difference was
not statistically significant and could have been so
skewed by the inclusion of 12 cases of
meningomyelocele.
The median age at presentation of neonatal bacterial
meningitis was 9 days (range, 0 - 27).
The mean birth weight of the babies was 2,377g
(range, 850 - 3,950) and the mean gestational age was
35.5 weeks (range, 26 - 42). Analysis of the overall
live deliveries revealed that there were 3,496 and
1,249 term and preterm babies, respectively. The
male: female ratio was 1.7:1. Of the inborn babies
with the disease, 21 were preterm while 10 were term,
with incidence of 16/1000 and 3.2 per 1000 detected
for both groups, respect ively ; =0.001.
Corresponding figures for out-born babies were 20
and 18, respectively. Table IAalso shows that preterm
was more predisposed to having bacterial meningitis,
41 28; =0.01.
The total number of low birth weight (LBW)
(<2,500g) infants delivered during study period was
1,026, compared with 3,247 and 472 of normal birth
weight ( 2500g) and very low birth weight (VLBW),
respectively. Fourteen, nine and 8 of these deliveries
developed bacterial meningitis, respectively (Table
IB). The incidence of bacterial meningitis was
highest among the VLBW group of newborns; being
17 per 1000 live births, while it was 2.8/1000 for
normal birth weight; X =24.19, =0.000001. The
incidence of meningitis for the LBW was 13.7/1000
live births. However, the difference between that of
the VLBW and LBW was not statistically significant.
Table IB further elucidates the specific rates in
relationship to birth weight and gestational age.
The other identified predisposing risk factors were
premature rupture of fetal membranes that later
became prolonged, i.e. > 24 hours of drainage (n=20),
presumed maternal bacteremia (chorioamnionitis or
maternal peripartum pyrexia) (n=15), congenital
anomalies, particularly of the nervous system (n=12),








(n=41), fast breathing (n=38),
Presenting Clinical Features
The symptoms and signs at presentation were mostly
protean, vague and non-specific. Commonly
mentioned problems were poor-feeding (n=47),
excessive crying and restlessness (n=42), fever; core
temperature =38.5oC
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vomiting (n=36) and seizures (n=31). All these
symptoms were also documented objectively, while
other signs comprised lethargy ((n=60), bradycardia
(n=25), bradypnea (slow respiratory rate) (n=16),
hypothermia; temperature <35.5 C (n=15) and
petechial hemorrhages (n=5). The main 'specific'
neurological signs encountered were stupor with or
without irritability (n=33), seizures (n=31),
tense/bulging anterior fontanelle (n=23), high-
pitched cry (n=14) and opisthotonus (n=6). The
seizure types were generalized tonic in 14, multi-
clonic; 10, and focal clonic; 5. The seizures were all
preceded and/or associated with subtle features.
Of the 50 babies with 'definite' neonatal bacterial
meningitis, 39 (78%) also had simultaneously
positive blood cultures (Table IIA). These blood
pathogens were 16 Gram-positive and 23 Gram-
negative bacteria as was also cultured in the CSF.
Table IIA also shows the relationship between the
blood pathogens identified in neonatal bacterial
meningitis and those seen in the CSF; as 78% of
these neonates with 'definite' neonatal bacterial
meningitis (n=50) and 'probable' neonatal bacterial
meningitis (n=5) also had the same pathogens
cultured in both CSF and blood. Furthermore, of the
total 'definite' neonatal bacterial meningitis, twenty-
two neonates had early-onset disease whilst late-
onset type occurred in 28. All the 22 neonates also
had proven positive cultures from their
simultaneously taken blood specimens as was
identified in their CSF. The remaining 19 neonates
had 'probable' neonatal bacterial meningitis, out of
which eleven cases had sterile CSF on culture but
with isolation of pathogens from simultaneously
obtained blood cultures; 2 with S. pneumoniae, N.
meningitidis, untyped, 1, and H. influenzae, untyped
in one. These sterile CSFs had significant
pleocytosis (= 200 WBC x 10 /L; 60%
polymorphonuclear leucocytes), which was further
confirmed when subjected to (latex agglutination)
immunodiagnosis.
The remaining 8 (11.6%) of 'probable' neonatal
bacterial meningitis did not have CSF sample for
analysis within the first 48 hours because of a)
severity of the illness in 5 neonates, b) extensive
defects in lumbar area, and c) late performance of
lumbar puncture(after 48 hours of stabilization and
therapy) in one full-term infant. The latter baby's
CSF was, however, traumatic but the WBC exceeded
the normal haemic proportions (1:800) by 200
cells/mm (55% polymorphonuclear (PMN) and
45% lymphocytes); and it was sterile on culture.
They all had highly suggestive 2 or more 'specific'





Bacteriology of Neonatal Meningitis
There was more Gram-negative CSF isolates (28)
compared to the Gram-positive isolates (22).
However, the commonest pathogen was , a
Gram-positive microbe that was isolated in 13 cases.
The commonest Gram-negative organism was
11, and this was followed by
, 7. It was noteworthy that some
unusual organisms, not commonly isolated in
neonatal bacterial meningitis, were encountered:
in two , type in one and
(untyped) in one case. They
contributed 0.6 and 2.2 per 1000 live births and
admissions, respectively, to the overall incidence and
proportion rates detected in study.
Gram-negative bacteria were generally more
involved in late-onset disease; 17 11 but
specifically, were most commonly isolated
in late-onset disease, followed by . However,
they both had equal propensity for early-onset
meningitis. was responsible for late-
onset disease.
Gram-negative pathogens caused almost
twice as much mortality as the Gram-positive
organisms; 11 (20%) 6 (10.9%). The
contribution of ; 9.1% was, however, the
highest of all isolated microbes.
The detected range of WBCs in CSF of 'definite'
neonatal bacterial meningitis was 17 - 3,950 x 10 /L,
with a mean of 647 and these were mainly PMN of
between 60% - 100% on differential analysis. The
CSF WBC was minimally raised (25 30 x10 /L) in
eleven (22%) and moderate; > 30 -100 x 10 /L in 15
(30%). However, values in the remaining 36% were
more than 100 x 10 /L, with only three having very
high WBC > 2,500 x 10 /L. In 6 cases of 'definite'
neonatal bacterial meningitis, CSF WBC was < 25
(range, 17 23 x10 /L).
We observed that out of the 19 cases of 'probable'
neonatal bacterial meningitis, CSF WBC in eleven
ranged from 200 to 4,760 x 10 /L. Blood culture and
CSF latex agglutination positively confirmed
and in 2 of these cases.
The 17 of twenty-two 'definite' neonatal bacterial
meningitis with minimally raised CSF WBC had
early-onset disease while the remaining 5 (22.7%)
had levels of < 60 x 10 /L; 2, and > 100 x 10 /L in 3.
Areview of antimicrobial sensitivity patterns to some
antibiotics (Table IIB) revealed that the
cephalosporins and gentamicin were more effective
against the Gram-negative microbes with over 90%
and 100% sensitivity against and
spp, respectively were less sensitive to
gentamicin as against findings, but
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generation cephalosporin (ceftazidime). However,
cefuroxime and ceftriazone provided 92%
sensitivity over the Gram-negative microbes. We
accede to the limited sample size of ,
spp and , as
were the spectrum of other relevant disks available
during the study. Sultamicillin; a sysnthetic
penicillin which is made of a combination of
'ampicillin sulbactam', showed 97% sensitivity
over the Gram-positive organisms. The sensitivity
patterns of and were very
similar to that of However, none of
the and tested proved
resistant to ceftriaxone and cefuroxime.
Cases fatality was in 17 (24.6%) while 31 infants
recovered fully without disability. Amongst the
survivors with poor outcome, evolving
neurological disabilities were noted; yielding a
morbidity rate of 9/69 (13.0%). Such disabilities
compr i sed senso r ineu ra l dea fn es s , 3 ;
hydrocephalus, 2; subdural effusion, 2;
hemiparesis, 1; and afebrile (recurrent) seizures, 1.
One of the hydrocephalus had meningitis caused by
, untyped, and an 'arrest' occurred at
the age of 4 months whilst on medical management
(acetazolamide and diuretics), and the second
( a s t h e a g e n t ) r e q u i r e d
ventriculoperitoneal shunt insertion.
No specific pathogen showed predisposition to any
particular disability, with
and differentially implicated in
a u d io l o g i c d e f i c i t s . T h e c a s e w i t h
recurrent/afebrile seizures had the problem
occurring from the age of 7 months. Seven of the
cases of meningomyelocele were lost to follow-up.
A higher mortality was evident in early-onset
disease as against late-onset; 12/22 (54.5%)
5/28 (17.9%), <0.001. Overall, LBW had more
risk for case fatality compared to normal birth
weight; 14/39 (35.9%) 3/18 (16.7%),
<0.01, and mortality was predominant in the
preterm, 13. There was no increased risk for
mortality detected for gender difference. On the
other hand, neonates who had raised CSF WBC and
protein were more predisposed to death. Other
encountered risk factors that increased mortality
included presence of very low CSF glucose, four
neonates (23.5%) with fatal neonatal bacterial
meningitis exhibited hypglycorrachia; and out-
born nature, as these showed a 4-fold rise in
mortality as against being in-born. This latter risk
factor was related to late presentation to hospital
and prior antibiotic use; 3/31 (9.7%) 14/38
(36.8%). Only 5/56 (8.9%) neonates required
repeat LP to ascertain reason for slow recovery
>
H. inflenzae N.
meningitidis, Citrobacter P. aeruginosa
S. epidermidis S. faecalis
S. pneumoniae.
S. aureus S. pneumoniae
H. influenzae
S . a u r e u s








and/or lack of good response, and confirm CSF
sterility or otherwise.
On fur ther analysis of contr ibut ion of
dexamethasone to outcome, its usage and effect was
analyzed in two phases of the study; Phase-1 and
Phase-2. A better overall outcome was revealed with
its usage as highlighted in Table III. The adjunct of
dexamethasone (n=7 and 21 in Phase-1 and Phase-2,
respectively), was associated with less mortality and
more survivors without disabilities. The difference
was particularly significant in Phase-2, when the use
of dexamethasone was more controlled and routinely
used alternately in study subjects. Furthermore, we
carried out intra-phase comparisons of outcome, and
there was significantly less mortality, ( =0.0004) and
better recovery; =0.007 in Phase2 of study. It is
pertinent that clinical care and other variables were
fairly constant during the study period, except for the
more constant usage of dexamethasone in the latter
h a l f o f t h e s t u d y - p e r i o d . N o s i d e -
effects/complications occurred in any infant. 3 cases
had persistent hearing disability whilst 1 had
transient hearing loss without dexamethasone
adjunct. It was notable that hearing reverted to
normal by 5 months of age in the infant with the
transient hearing loss.
Also noteworthy was the result on analysis of effect
of steroids the nature of the causative
microbe and mortality. In Phase-1, there was more
preponderant case fatality among Gram-negative
microbes without the use of dexamethasone; n=5
(60%) as against its usage, n=4 (25%), = 0.001. It is
pertinent to note that a highly significant mortality
was observed with out the use of dexamethasone in
Phase-2, irrespective of nature of microbes. No
deaths occurred amongst neonates who had Gram-
positive agents (n=7) 60% in those in which
the steroid adjunct was not offered, =0.0001. A
similar pattern was notable for the Gram-negative
microbes, where 7.1 %( n=14) and 63.6 %( n=11)
mortality occurred with and without the use of
dexamethasone as treatment adjunct, respectively.
At regular follow-up, surviving infants had frequent
assessments of developmental status. Results of
assessment using Griffiths' Mental Development
Scales done at 24 months in 35 infants were
compared in different groups. Comparisons were
made between time of onset of infection, and the use,
or not, of dexamethasone with both times of onset
combined. Neurological outcome was poorest in
infants with early onset disease (n=14) and the
assessment scores/performance of infants who
received dexamethasone adjunct (n=15) were higher,
although the lack of use (n=18) did not produce any
unfavorable developmental status, mean (SD)
mental age; 103.8 (1.8) 102.1 (2.0).
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Table IB: Incidence of Neonatal Bacterial Meningitis






was highly statistically significant, X =24.19,
= 0.000001
also statistically different, = 0.0001
2
Table IA:
n = 14, Early-Onset; for Inborn babies
n = 17, Late-Onset; for Inborn babies
* Inborn babies in parentheses.
+ Higher risk of meningitis in low birth weight, =
0.000001; X = 24.19.
No significant difference, = 0.51, X = 0.42.
Higher risk for preterm, < 0.001.
Onset of Neonatal Bacterial Meningiti in










Table IIA: CSF and Blood Pathogens of Newborn Bacterial Meningitis and Onset in Relation to Mortality
(n = 55)
+
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DISCUSSION
The incidence of 6.5/1000 live births of neonatal
bacterial meningitis confirmed an increasing trend in
Nigeria when other areas are maintaining a relatively
stable level, for instance, rates of 0.32/1000 in the
Netherlands, 0.25-0.32 per 1000 in England,
0.99/1000; North America and 0.69 1.9/1000 in
other regions of Africa. Further glaring is our
exceedingly high rate which surpassed a previous rate
of 1.9 per 1000 in another area of this country, though
in agreement with the noted evidence of increasing
trend of bacterial meningitis. We must admit that our
referral hospital, which also serves three other
contiguous countries, may have had a bias for more
admissions of high-risk pregnancies that reside great
distances away to a tertiary hospital. Such a scenario
would be different from another hospital that receives
a larger proportion of lower-risk pregnancies from
nearby locations. However, it remains pertinent that
the rate of infection and its surveillance method,
poor hygienic condition, requires more vigorous
assessment and good control of infections in the
developing world.
Similarly intriguing was the was finding of a 6-fold
increase in the incidence of neonatal bacterial
meningitis amongst the LBW infants, and this is
consistent with previous studies. Our study also
confirmed that the preterm was more significantly
exposed to the risk of bacterial meningitis overall; <
0.0001.These gestational-, and birth weight-related
patterns of increased risk result from the complex












Disabilities/handicaps included; Hearing deficit
( pe rmanen t ) , 3 ; S ubdura l e ffus ion , 2 ;
Hydrocephalus , 2; Hemiparesis , 1; and
Afebrile/Recurrent Seizure, 1.
Significantly less mortality in shown in Phase 2, X
= 12.2, = 0.006.
*Yates' corrected X = 0.04, = 0.84
*Yates' corrected X = 0.09, = 0.76
** X = 12.3, = 0.0004.
Use of Steroids (Dexamethasone) and the











+ n = 50 in 'definite' neonatal bacterial meningitis.
n = 5 in “sterile” CSF culture, i.e. 'probable' neonatal bacterial meningitis.
Table IIB:
*a stable ampicillin sulbactam combination, with the trade-name Unasyn®
CSF = Cerebrospinal fluid Sp = Ec =
Ko = Co = spp. C i t = s p p
Nm = Hi = Pa =
Chloramphen = Chloramphenicol NT = Not tested
Antibiogram of Some CSF Bacterial Isolates
Abbreviations:
beta-lactamase
Streptococcus pneumoniae Escherichia coli
Klebsiella oxytoca Coliform C i t ro b a c t e r
Neisseria meningitides Haemophylus influenzae Pseudomonas aeruginosa
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microbial characteristics. The younger and smaller
neonate is particularly vulnerable to bacterial disease
because of the well known inadequate maturation of
cell and antibody mediated immune mechanisms,
coupled with other physical factors. Wenger et al de
Louvois and Hristeva had earlier shown
similar trend for the preterm.
The etiologic spectrum of neonatal bacterial
meningitis in our unit was noteworthy: there was the
emergence of unusual pathogens. The commonest
single pathogen overall was a Gram-positive
organism, . No GBS and
were isolated despite their common frequency in other
regions. The lack of GBS further confirms the
observations by others that this pathogen is an
uncommon cause of disease in Nigeria. The
reasons for such a rarity are not clear but it could
speculated to be related to the methods employed in
maintaining genital hygiene, such as douching, or
some other unexplained familial/genetic inhibitory
capacity against the GBS pathogen. However, our
encounter of neonatal bacterial meningitis caused by
was intriguing since such pattern was
rare, in spite of the hospital being within the African
“meningitis belt”.
Only one case of neonatal bacterial meningitis caused
by and none causal to
was encountered over a 10-year period by Fortnum
and Davis. Although Wenger found no
but a few meningitis over a
similar period, their opinion being that neonatal
disease is more likely to be caused by non-type
strains, was not supported by our finding. The
, type in our study was invasive and it had
also been isolated from simultaneous blood culture
specimen. The rarity of these isolates causing
meningitis has been attributed to the acquisition of
maternal antibodies directed against capsular
antigens, and to a lesser extent by the
immunological effect of breast-feeding. It is possible
that the observed emerging trend in our study,
therefore, may be related to a rapidly waning maternal
humoral immunity.
In view of the associated high mortality and
neurological sequelae, an early diagnosis requires
diligence and high priority. However, because
clinical assessment cannot distinguish septicemic
infants with coexisting meningitis from those without
meningitis, it is vital to do blood culture alongside the
lumbar puncture for CSF evaluation. The
documentation of 15% neonatal bacterial meningitis
being associated with concomitant negative blood
culture and 85.7% positive blood culture ( over a 7-
year period ) is in consonance with the 78% positive
culture rate seen in the present study. Therefore, with
such an increased probability of simultaneous
isolation of pathogens via blood culture (particularly
of early-onset), it is mandatory that a blood culture
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Hendricks-Munoz and Shapiro have shown that
meningitis in the first six hours of life is unusual, and
that the value of CSF examination is minimal in this
age-group (<48 hours of age). The pattern of CSF
disturbance in our neonatal bacterial meningitis was
revealing. Though a diagnosis of bacterial
meningitis cannot be excluded by a normal CSF
chemistry or a normal CSF WBC, a minimally
raised WBC (25-30x10 /1) was seen in 22% of the
'definite' cases in this study while 6 (12%) had levels
further lower. A low CSF WBC in the presence of
infection may be due to possible interplay of
previous antibiotic exposure and/or poor mounting
of inflammatory response, or some other
genetic/regional difference. The latex agglutination
test was not used routinely in all our cases but was
only employed as a valuable supportive tool to the
routine bacteriological examination of CSF, as
opined by Varaine
The overall mortality was 24.6%, with the Gram-
negative pathogens being about two-fold more than
the Gram-positive. Although not a randomized
evaluat ion, however, the routine usage
dexamethasone as an adjunct along or before the first
antibiotic was significantly associated with less
mortality, < 0.0004, ÷ = 12.3 (Table III). There
was no permanent hearing deficit identified amongst
the survivors with disabilities who had adjunctive
dexamethasone, while three had sensorineural
deafness without it. The pathogenesis of the hearing
disabilities was thought to be acquired via the
meningitic process i.e. the inflammatory
involvement of the cochlea and labyrinth
structures. Furthermore, our strict consideration
of the adverse risk criteria for the occurrence of
congenital auditory deficits, assisted the
verification of acquired sensorineural hearing loss.
It is possible that more mild hearing loss may have
been detected by BAER, had it been used in this
study.
This improved outcome with adjunctive
dexamethasone corroborates the suggestions of
other workers. Most of these studies have not
been done on neonates, but an older infants and
children. However, studies from developing
countries had not shown such benefits and none of
these clinical studies or assessments was also
focused on neonates. This is in spite of the
longstanding evidence that much of the cerebral
damage is the direct consequence of the activation of
host inflammatory pathways rather than a direct
effect of the invading organism It must be said
that some clinicians are wary of using
dexamethasone because it may mask the
presentation of underlying infections, and hence do
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Although we accede that our dexamethasone offer in
the second-half of study period was unselective,
however, the treatment offered covered the same
trend of disease profile, especially in the in-born
infants. Furthermore, we must acquiesce that our
dexamethasone data are not the result of a
randomized evaluation.
The efficacy of mannitol in the management of
cerebral edema/raised ICP remains controversial and
debatable. Levene have found it only useful in
raised ICPfrom perinatal asphyxial insult.
The best antimicrobials included gentamicin and
ceftazidime until the sensitivity differential is
ascertained. Cloxacillin had to be dropped from
empiric use in view of report of its ineffectiveness
and as was noted during study. It is pertinent that our
empiric antibiotic use was at variance with the
developed/aff luent countr ies where the
cephalosphorins are of standard usage. However,
their costs are excessive in our nations' setting.
Sultamicillin (synthetic penicillin) would be an
effective alternative in the parenteral form, as
appropriate cover was provided against both Gram-
positive and Gram-negative organisms, and its
efficacy has previously been documented. Finally,
with such high rate of CSF cultures that grew mostly
Gram-positive organisms, vancomycin (though not
tested against) could be a good initial empiric
treatment.
In conclusion, our research has revealed a changing
trend of neonatal bacterial meningitis with emerging
new pathogens in Nigeria, and better outcome with
adjunctive dexamethasone. It is pertinent that all
survivors should be referred for full neuromotor and
audiological assessments for early detection of
sequelae, learning or developmental disabilities, or
communication disorders. All feasible efforts
should be proffered for infection control, continuing
epidemiology and further expert surveillance.
Furthermore, larger studies to delineate the
significant CSF WBC cut-off level that correlates
with 'definite' neonatal bacterial meningitis and the
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